We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
-3.77%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$117B
AUM Growth
-$71.4B
(-38%)
Cap. Flow
-$63.6B
Cap. Flow
% of AUM
-54.42%
Top 10 Holdings %
Top 10 Hldgs %
19.61%
Holding
4,580
New
101
Increased
1,974
Reduced
1,229
Closed
1,024
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$190M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$160M |
| 3 |
Microsoft
MSFT
|
+$150M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$136M |
| 5 |
Bank of America
BAC
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$306M |
| 2 |
Linde
LIN
|
+$290M |
| 3 |
Principal Financial Group
PFG
|
+$279M |
| 4 |
Evergy
EVRG
|
+$277M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.91% |
| 2 | Healthcare | 15.27% |
| 3 | Financials | 13.61% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
BARK
BARK
$100M
| $140K | ﹤0.01% |
1,889
-1,350
| -42% | -$96.1K |
|
|
FXLV
3302
DELISTED
F45 Training Holdings Inc.
FXLV
| $140K | ﹤0.01% |
+13,112
| New | +$170K |
|
|
EPIX
3303
DELISTED
ESSA Pharma
EPIX
| $139K | ﹤0.01% |
22,306
+9,933
| +80% | +$87.3K |
|
|
TRHC
3304
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $136K | ﹤0.01% |
23,827
+1,261
| +6% | +$11.3K |
|
|
ONTF
3305
DELISTED
ON24
ONTF
| $133K | ﹤0.01% |
+10,092
| New | +$152K |
|
|
LCI
3306
DELISTED
Lannett Company, Inc.
LCI
| $133K | ﹤0.01% |
42,187
-9,014
| -18% | -$39.6K |
|
3307
Evolv Technologies
EVLV
$1.1B
| $132K | ﹤0.01% |
49,999
+2,860
| +6% | +$9.35K |
|
3308
Cullinan Oncology
CGEM
$1.14B
| $131K | ﹤0.01% |
12,389
-798
| -6% | -$10.8K |
|
3309
Rimini Street
RMNI
$471M
| $131K | ﹤0.01% |
22,450
+1,464
| +7% | +$7.69K |
|
|
EPZM
3310
DELISTED
Epizyme, Inc
EPZM
| $129K | ﹤0.01% |
112,305
+20,066
| +22% | +$32.7K |
|
|
SURF
3311
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $126K | ﹤0.01% |
42,718
-2,196
| -5% | -$7.7K |
|
|
MKFG
3312
DELISTED
Markforged Holding Corporation
MKFG
| $121K | ﹤0.01% |
3,029
+207
| +7% | +$9.06K |
|
|
GATO
3313
DELISTED
Gatos Silver, Inc.
GATO
| $120K | ﹤0.01% |
27,620
+1,444
| +6% | +$7.95K |
|
3314
Atea Pharmaceuticals
AVIR
$415M
| $118K | ﹤0.01% |
16,270
-2,991
| -16% | -$20.3K |
|
|
FMTX
3315
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $118K | ﹤0.01% |
12,709
-1,490
| -10% | -$15.9K |
|
|
GAN
3316
DELISTED
GAN Ltd
GAN
| $117K | ﹤0.01% |
24,087
-702
| -3% | -$4.52K |
|
|
TGA
3317
DELISTED
Transglobe Energy Corp
TGA
| $116K | ﹤0.01% |
+31,900
| New | +$108K |
|
3318
Cipher Digital
CIFR
$7.09B
| $113K | ﹤0.01% |
31,348
+1,990
| +7% | +$6.39K |
|
3319
Cue Biopharma
CUE
$114M
| $108K | ﹤0.01% |
735
+49
| +7% | +$10.4K |
|
|
HEXO
3320
DELISTED
HEXO Corp. Common Shares
HEXO
| $107K | ﹤0.01% |
12,243
+2,400
| +24% | +$20.4K |
|
3321
CEL-SCI Corp
CVM
$29.2M
| $106K | ﹤0.01% |
904
+53
| +6% | +$8.63K |
|
3322
Curis
CRIS
$7.91M
| $105K | ﹤0.01% |
109
+6
| +6% | +$7.66K |
|
3323
The Honest Company
HNST
$599M
| $105K | ﹤0.01% |
20,066
-331
| -2% | -$1.99K |
|
|
ZYXI
3324
DELISTED
Zynex
ZYXI
| $105K | ﹤0.01% |
16,903
+1,038
| +7% | +$7.29K |
|
3325
Aveanna Healthcare
AVAH
$2.06B
| $102K | ﹤0.01% |
29,923
+2,030
| +7% | +$11K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2022 Portfolio in Review
As of Q1 2022, Credit Suisse held 4,580 positions worth $117B, down 38% from $188B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Credit Suisse withdrew a net $63.6B in Q1 2022, closing 1,024 positions and reducing 1,229 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $240M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in AgileThought Inc worth $43.7M.
- Credit Suisse's largest Q1 2022 buy was AgileThought Inc: 9,605,775 shares worth $43.7M.
- Credit Suisse added most to S&P Global in Q1 2022, an estimated $190M increase.
- Credit Suisse's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $306M.
- Credit Suisse fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $240M.
- Credit Suisse's ten largest holdings make up 20% of its $117B portfolio in Q1 2022.
- Credit Suisse opened 101 new positions and closed 1,024 in Q1 2022.
- Credit Suisse's portfolio value fell 38% quarter-over-quarter to $117B.
Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.